Bachem Aktie
WKN: 914589 / ISIN: CH0012530207
16.10.2024 09:20:30
|
PUSHING THE BOUNDARIES of Peptide and oligonucleotide purification
During the manufacturing of a peptide API, well-established purification is crucial for achieving high purity and yield, and at the same time is a major determinant for the cost efficiency and process productivity.Multicolumn Countercurrent Solvent Gradient Purification (MCSGP) has shown to achieve substantially higher capacity and yield than single-column batch processes. This innovative purification process leads to time savings, economic advantages and a lower environmental footprint.Key Highlights:Efficiency and Sustainability: MCSGP technology revolutionizes purification making it a game-changer in sustainable manufacturing.Automation and Productivity: Operating 24/7, MCSGP’s fully automated system eliminate extra purification steps and significantly enhancing productivity.Economic and Environmental Impact: This innovative process not only reduces raw material costs and process mass intensity (PMI) but also supports environmental sustainability by minimizing the purification process’s footprint. To download the entire resource, please complete the form.The post PUSHING THE BOUNDARIES of Peptide and oligonucleotide purification appeared first on Bachem.Weiter zum vollständigen Artikel bei Bachem Holding AG

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Bachem AGmehr Nachrichten
Keine Nachrichten verfügbar. |